Search This Blog

Tuesday, January 4, 2022

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Immunocompromised Children

 Today, CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine.  This means that people can now receive an mRNA booster shot 5 months after completing their Pfizer-BioNTech primary series.  The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed.

Additionally, consistent with our prior recommendation for adults, CDC is recommending that moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children aged 5-11.

https://www.cdc.gov/media/releases/2022/s0104-Pfizer-Booster.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.